OraSure Technologies to Present at Rodman & Renshaw Techvest Global Healthcare Conference

BETHLEHEM, Pa.--(BUSINESS WIRE)--May 4, 2004--OraSure Technologies, Inc. (Nasdaq NM:OSUR) today announced that Mike Gausling, President and Chief Executive Officer, and Ronald H. Spair, Executive Vice President and Chief Financial Officer, will speak to the investment community at the Rodman & Renshaw Techvest Global Healthcare Conference in London, England. The conference will be simultaneously webcast over the Internet.

Messrs. Gausling and Spair are scheduled to speak on May 13, 2004, at approximately 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). Interested investors can access the live audio with slides webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link. A replay of the audio webcast with slides will be available on OraSure Technologies' web site for seven days.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices and tests and other diagnostic products using its proprietary technologies, including immunoassays and other in vitro diagnostic tests and other medical devices. These products are sold in the United States and certain foreign countries to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. For more information on the Company, please visit www.orasure.com.

    CONTACT: OraSure Technologies, Inc.
             Ronald H. Spair, 610-882-1820
             Investorinfo@orasure.com
             www.orasure.com

    SOURCE: OraSure Technologies, Inc.